Literature DB >> 36105494

Digestive involvement in COVID-19: what we have learned in the past 12 months.

Vladimir Posmag1, Liliana David2, Dan L Dumitrascu1.   

Abstract

Background and aim: The year 2020 will remain in the medical history as the year of COVID-19 pandemic. Although COVID-19 is considered mainly a respiratory disease, it is well known now that SARS-CoV-2 can affect major organs including the digestive system. This is a comprehensive review on gastrointestinal involvement in the SARS-CoV-2 infection, also the digestive damage due to COVID-19.
Methods: A literature search was undertaken in main databases of medical publications following the search items digestive or gastrointestinal or gastric or enteral and SARS-CoV-2 or COVID-19. Data on gastrointestinal symptoms and alterations in this viral condition were collected and presented. Only observational studies were included.
Results: In this review we discuss the recent information on the relationship between COVID-19 and the digestive system. The putative underlying pathogenic mechanisms of COVID-19 as well as the clinical findings in relation to gastrointestinal changes are presented. Conclusions: SARS-CoV-2 virus can affect any part of the digestive system. Patients with chronic diseases are at greatest risk of adverse out-comes. There is a considerable risk for drug-drug interactions in patients who require a large treatment schedule.

Entities:  

Keywords:  COVID-19; SARS-Cov-2 infection; gastrointestinal tract; liver diseases; pancreas

Year:  2021        PMID: 36105494      PMCID: PMC9389867          DOI: 10.15386/mpr-2061

Source DB:  PubMed          Journal:  Med Pharm Rep        ISSN: 2602-0807


  45 in total

1.  A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

Authors:  M Donoghue; F Hsieh; E Baronas; K Godbout; M Gosselin; N Stagliano; M Donovan; B Woolf; K Robison; R Jeyaseelan; R E Breitbart; S Acton
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

2.  [A pathological report of three COVID-19 cases by minimal invasive autopsies].

Authors:  X H Yao; T Y Li; Z C He; Y F Ping; H W Liu; S C Yu; H M Mou; L H Wang; H R Zhang; W J Fu; T Luo; F Liu; Q N Guo; C Chen; H L Xiao; H T Guo; S Lin; D F Xiang; Y Shi; G Q Pan; Q R Li; X Huang; Y Cui; X Z Liu; W Tang; P F Pan; X Q Huang; Y Q Ding; X W Bian
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2020-05-08

Review 3.  Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic.

Authors:  Rashid N Lui; Sunny H Wong; Sergio A Sánchez-Luna; Gianluca Pellino; Steven Bollipo; Mei-Yin Wong; Philip W Y Chiu; Joseph J Y Sung
Journal:  J Gastroenterol Hepatol       Date:  2020-04-22       Impact factor: 4.029

4.  Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.

Authors:  Erica J Brenner; Ryan C Ungaro; Richard B Gearry; Gilaad G Kaplan; Michele Kissous-Hunt; James D Lewis; Siew C Ng; Jean-Francois Rahier; Walter Reinisch; Frank M Ruemmele; Flavio Steinwurz; Fox E Underwood; Xian Zhang; Jean-Frederic Colombel; Michael D Kappelman
Journal:  Gastroenterology       Date:  2020-05-18       Impact factor: 22.682

5.  High rates of 30-day mortality in patients with cirrhosis and COVID-19.

Authors:  Massimo Iavarone; Roberta D'Ambrosio; Alessandro Soria; Michela Triolo; Nicola Pugliese; Paolo Del Poggio; Giovanni Perricone; Sara Massironi; Angiola Spinetti; Elisabetta Buscarini; Mauro Viganò; Canio Carriero; Stefano Fagiuoli; Alessio Aghemo; Luca S Belli; Martina Lucà; Marianna Pedaci; Alessandro Rimondi; Maria Grazia Rumi; Pietro Invernizzi; Paolo Bonfanti; Pietro Lampertico
Journal:  J Hepatol       Date:  2020-06-09       Impact factor: 25.083

6.  Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.

Authors:  Ka Shing Cheung; Ivan F N Hung; Pierre P Y Chan; K C Lung; Eugene Tso; Raymond Liu; Y Y Ng; Man Y Chu; Tom W H Chung; Anthony Raymond Tam; Cyril C Y Yip; Kit-Hang Leung; Agnes Yim-Fong Fung; Ricky R Zhang; Yansheng Lin; Ho Ming Cheng; Anna J X Zhang; Kelvin K W To; Kwok-H Chan; Kwok-Y Yuen; Wai K Leung
Journal:  Gastroenterology       Date:  2020-04-03       Impact factor: 22.682

7.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

8.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

9.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

10.  The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection: A Systematic Review and Meta-Analysis.

Authors:  Zi-Yuan Dong; Bing-Jie Xiang; Min Jiang; Ming-Jun Sun; Cong Dai
Journal:  J Clin Gastroenterol       Date:  2021-01       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.